ArticleHIV/AIDS (Auckland, N.Z.)2017

Response by gender of HIV-1-infected subjects treated with abacavir/lamivudine plus atazanavir, with or without ritonavir, for 144 weeks.

Kathleen E Squires et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.